Joshua N. Silverman - 20 Nov 2023 Form 4 Insider Report for PharmaCyte Biotech, Inc. (PMCB)

Role
Interim CEO, Interim President, Director
Signature
/s/ Joshua N. Silverman
Issuer symbol
PMCB
Transactions as of
20 Nov 2023
Net transactions value
$0
Form type
4
Filing time
22 Nov 2023, 17:01:23 UTC
Previous filing
03 Aug 2023
Next filing
22 Nov 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMCB Stock Option (Right to Buy) Award $0 +170,000 $0.000000 170,000 20 Nov 2023 Common Stock 170,000 $2.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest 50% on November 20, 2023 and 50% on November 20, 2024.